The researchers identified a previously unknown, freely circulating form of a brain protein called ‘Cacna2d1’ — levels of the protein were reduced among patients with schizophrenia, compared to the healthy participants, resulting in overactive or overexcited brain circuits.
News
Study finds new biomarker for cognitive symptoms of schizophrenia, could serve as drug target
March 23, 2026The researchers identified a previously unknown, freely circulating form of a brain protein called ‘Cacna2d1’ — levels of the protein were reduced among patients with schizophrenia, compared to the healthy participants, resulting in overactive or overexcited brain circuits.